Assessment of Circulating Tumor Cells and Serum Markers for Progression-free Survival Prediction in Metastatic Breast Cancer: a Prospective Observational Study

被引：0
|
作者：
Pierga, J. Y. [1 ]
Hajage, D. [2 ]
Bachelot, T. [3 ]
Delaloge, S. [4 ]
Brain, E. [5 ]
Campone, M. [6 ]
Cottu, P. H. [1 ]
Beuzeboc, P. [1 ]
Rolland, E. [2 ]
Bidard, F. C. [1 ]
机构：
[1] Inst Curie, Dept Med Oncol, Paris, France
[2] Inst Curie, Dept Biostat, Paris, France
[3] Ctr Leon Berard, Dept Med Oncol, F-69373 Lyon, France
[4] Inst Gustave Roussy, Dept Med Oncol, Villejuif, France
[5] Inst Curie, Dept Med Oncol, St Cloud, France
[6] Inst Cancerol Ouest, Nantes, France
来源：
EUROPEAN JOURNAL OF CANCER | 2012年 / 48卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S146 / S146
页数：1
相关论文
共 50 条
  • [41] Elevated pretreatment serum activin A and progression-free and overall survival in trastuzumab-treated metastatic breast cancer.
    Lipton, Allan
    Zubritsky, Lindsey
    Leitzel, Kim
    Ali, Suhail M.
    Koestler, Wolfgang
    Fuchs, Eva-Maria
    Costa, Luis
    Knight, Robert D.
    Laadem, Abderrahmane
    Sherman, Matthew L.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [42] Serum thymidine kinase activity is an independent prognostic factor for progression-free and overall survival in women with metastatic breast cancer
    Larsson, Anna-Maria
    Jansson, Sara
    Bendahl, Par-Ola
    Baker, Sara
    Bergqvist, Mattias
    Aaltonen, Kristina
    Ryden, Lisa
    CANCER RESEARCH, 2018, 78 (04)
  • [43] Panitumumab improves progression-free survival in metastatic colorectal cancer
    不详
    ONCOLOGY-NEW YORK, 2005, 19 (14): : 1800 - 1801
  • [44] Rucaparib extends progression-free survival in metastatic prostate cancer
    Franke, Katharina
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2023, 148 (21) : 1341 - 1341
  • [45] Association of Metabolic, Inflammatory, and Tumor Markers With Circulating Tumor Cells in Metastatic Breast Cancer
    Lohmann, Ana Elisa
    Dowling, Ryan J. O.
    Ennis, Marguerite
    Amir, Eitan
    Elser, Christine
    Brezden-Masley, Christine
    Vandenberg, Theodore
    Lee, Elma
    Fazaee, Kamran
    Stambolic, Vuk
    Goodwin, Pamela J.
    Chang, Martin C.
    JNCI CANCER SPECTRUM, 2018, 2 (02)
  • [46] Evaluation of tumor response, disease control, progression-free survival, and time to progression as potential surrogate end points in metastatic breast cancer
    Burzykowski, Tomasz
    Buyse, Marc
    Piccart-Gebhart, Martine J.
    Sledge, George
    Carmichael, James
    Lueck, Hans-Joachim
    Mackey, John R.
    Nabholtz, Jean-Marc
    Paridaens, Robert
    Biganzoli, Laura
    Jassem, Jacek
    Bontenbal, Marijke
    Bonneterre, Jacques
    Chan, Stephen
    Basaran, Gul Atalay
    Therasse, Patrick
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (12) : 1987 - 1992
  • [47] Circulating HER2 extracellular domain (ECD) levels are associated with progression-free survival in metastatic breast cancer patients
    Wang, X-J
    Shao, X-Y
    Chen, Z-H
    Ye, W-W
    Qin, J.
    Zhang, Y- M.
    Zheng, Y-B
    Yu, X-Y
    Lei, L.
    Ling, Z-Q
    Feng, J-G
    Han, M. X.
    CANCER RESEARCH, 2012, 72
  • [48] Relationship of circulating tumor cells and Epstein-Barr virus DNA to progression-free survival and overall survival in metastatic nasopharyngeal carcinoma patients
    You, Rui
    Liu, You-Ping
    Lin, Mei
    Huang, Pei-Yu
    Tang, Lin-Quan
    Zhang, Yi-Nuan
    Pan, Yi
    Liu, Wan-Li
    Guo, Wei-Bang
    Zou, Xiong
    Zhao, Ke-Ming
    Kang, Ting
    Liu, Li-Zhi
    Lin, Ai-Hua
    Hong, Ming-Huang
    Mai, Hai-Qiang
    Zeng, Mu-Sheng
    Chen, Ming-Yuan
    INTERNATIONAL JOURNAL OF CANCER, 2019, 145 (10) : 2873 - 2883
  • [49] Detection of Circulating Tumor Cells Prior to Autologous Stem Cell Transplantation Is Predictive of Shorter Progression Free Survival in Metastatic Breast Cancer
    Gao, H.
    Lee, B-N
    Cohen, E. N.
    Mego, M.
    Davis, M. L.
    Giordano, A.
    Cristofanilli, M.
    Ueno, N. T.
    Reuben, J. M.
    CANCER RESEARCH, 2010, 70
  • [50] The impact of radiological assessment schedules on progression-free survival in metastatic breast cancer: A systemic review and meta-analysis
    Dabush, Dor Reuven
    Shepshelovich, Daniel
    Shochat, Tzippy
    Tibau, Ariadna
    Amir, Eitan
    Goldvaser, Hadar
    CANCER TREATMENT REVIEWS, 2021, 100
12345